Novozymes – the world leader in biological solutions – announced that it has increased prices of its Fungamyl products by up to 10%. The price increase is with immediate effect, but existing contracts will not be affected. 
Fungamyl is a fungal alpha-amylase, which helps correct a common flour deficiency and ensures consistent bread quality through the use of standardized flour. It provides increased loaf volume, improves the brown crust color of baked goods, and ensures a fine and uniform crumb structure.

“The cost to serve well the Fungamyl product range requires us to reassess our pricing. We have seen some of our critical cost elements increasing, and we wish to be able to continue with our substantial investments in innovation to deliver quality, sustainability and productivity improvements to our baking and flour milling customers,” explains Sandro Tomita, Global Marketing Manager for Baking.

Media contact: Frederik Bjørndal